Literature DB >> 30478144

hnRNP Q Regulates Internal Ribosome Entry Site-Mediated fmr1 Translation in Neurons.

Jung-Hyun Choi1, Sung-Hoon Kim2, Young-Hun Jeong1, Sung Wook Kim2, Kyung-Tai Min3,4, Kyong-Tai Kim5,2.   

Abstract

Fragile X syndrome (FXS) caused by loss of fragile X mental retardation protein (FMRP), is the most common cause of inherited intellectual disability. Numerous studies show that FMRP is an RNA binding protein that regulates translation of its binding targets and plays key roles in neuronal functions. However, the regulatory mechanism for FMRP expression is incompletely understood. Conflicting results regarding internal ribosome entry site (IRES)-mediated fmr1 translation have been reported. Here, we unambiguously demonstrate that the fmr1 gene, which encodes FMRP, exploits both IRES-mediated translation and canonical cap-dependent translation. Furthermore, we find that heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) acts as an IRES-transacting factor (ITAF) for IRES-mediated fmr1 translation in neurons. We also show that semaphorin 3A (Sema3A)-induced axonal growth cone collapse is due to upregulation of hnRNP Q and subsequent IRES-mediated expression of FMRP. These data elucidate the regulatory mechanism of FMRP expression and its role in axonal growth cone collapse.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  FMRP; Fmr1; IRES; hnRNP Q; neuron; translation

Mesh:

Substances:

Year:  2019        PMID: 30478144      PMCID: PMC6362317          DOI: 10.1128/MCB.00371-18

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  The 5'-untranslated region of the FMR1 message facilitates translation by internal ribosome entry.

Authors:  P W Chiang; L E Carpenter; P J Hagerman
Journal:  J Biol Chem       Date:  2001-08-06       Impact factor: 5.157

2.  Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling.

Authors:  Pin-Tse Lee; Po-Kuan Chao; Li-Chin Ou; Jian-Ying Chuang; Yen-Chang Lin; Shu-Chun Chen; Hsiao-Fu Chang; Ping-Yee Law; Horace H Loh; Yu-Sheng Chao; Tsung-Ping Su; Shiu-Hwa Yeh
Journal:  Nucleic Acids Res       Date:  2014-10-31       Impact factor: 16.971

Review 3.  Mechanisms of axon guidance: membrane dynamics and axonal transport in semaphorin signalling.

Authors:  Fanny Mann; Geneviève Rougon
Journal:  J Neurochem       Date:  2007-04-17       Impact factor: 5.372

4.  Control of mammalian translation by mRNA structure near caps.

Authors:  Jeremy R Babendure; Jennie L Babendure; Jian-Hua Ding; Roger Y Tsien
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

5.  Translation initiation mediated by RNA looping.

Authors:  Ki Young Paek; Ka Young Hong; Incheol Ryu; Sung Mi Park; Sun Ju Keum; Oh Sung Kwon; Sung Key Jang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

6.  Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs.

Authors:  M Kozak
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

Review 7.  Semaphorin signalling during development.

Authors:  Bart C Jongbloets; R Jeroen Pasterkamp
Journal:  Development       Date:  2014-09       Impact factor: 6.868

8.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

Review 9.  Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.

Authors:  Stéphane Oudard; Jacques Medioni; Jorge Aylllon; Eduardo Barrascourt; Reza-Thierry Elaidi; José Balcaceres; Florian Scotte
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

10.  CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome.

Authors:  Peter K Todd; Seok Yoon Oh; Amy Krans; Fang He; Chantal Sellier; Michelle Frazer; Abigail J Renoux; Kai-chun Chen; K Matthew Scaglione; Venkatesha Basrur; Kojo Elenitoba-Johnson; Jean P Vonsattel; Elan D Louis; Michael A Sutton; J Paul Taylor; Ryan E Mills; Nicholas Charlet-Berguerand; Henry L Paulson
Journal:  Neuron       Date:  2013-04-18       Impact factor: 17.173

View more
  6 in total

1.  hnRNP K Supports High-Amplitude D Site-Binding Protein mRNA (Dbp mRNA) Oscillation To Sustain Circadian Rhythms.

Authors:  Paul Kwangho Kwon; Kyung-Ha Lee; Ji-Hyung Kim; Sookil Tae; Seokjin Ham; Young-Hun Jeong; Sung Wook Kim; Byunghee Kang; Hyo-Min Kim; Jung-Hyun Choi; Hee Yi; Hyun-Ok Ku; Tae-Young Roh; Chunghun Lim; Kyong-Tai Kim
Journal:  Mol Cell Biol       Date:  2020-02-27       Impact factor: 4.272

Review 2.  Expression of Genes Involved in Axon Guidance: How Much Have We Learned?

Authors:  Sung Wook Kim; Kyong-Tai Kim
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

3.  SRSF protein kinase 1 modulates RAN translation and suppresses CGG repeat toxicity.

Authors:  Yi-Ju Tseng; Shannon E Wright; Indranil Malik; Kristina Zheng; Prithika Ramaiyer; Katelyn M Green; Peter K Todd
Journal:  EMBO Mol Med       Date:  2021-09-20       Impact factor: 12.137

4.  Isoprocurcumenol Supports Keratinocyte Growth and Survival through Epidermal Growth Factor Receptor Activation.

Authors:  Paul Kwangho Kwon; Sung Wook Kim; Ranjit De; Sung Woo Jeong; Kyong-Tai Kim
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 5.  Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development.

Authors:  Rita Marques; Rafaela Lacerda; Luísa Romão
Journal:  Biomedicines       Date:  2022-08-02

6.  hnRNP Q and hnRNP A1 Regulate the Translation of Cofilin in Response to Transient Oxygen-Glucose Deprivation in Hippocampal Neurons.

Authors:  Sung Wook Kim; In Kyung Hong; Mingee Kim; Yun Seon Song; Kyong-Tai Kim
Journal:  Cells       Date:  2021-12-17       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.